CORCEPT THERAPEUTICS INC (CORT)
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Address
101 REDWOOD SHORES PARKWAY
REDWOOD CITY, CA 94065
Founded
1998
Number of Employees
352
Website
http://www.corcept.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | $16 | $31 | $11 | $296 | $46 | $173 | - | $95 |
| Average Price | - | - | - | - | $13.10 | $11.14 | $20.12 | $21.35 | $24.78 | $22.73 | - | $20.55 |
| # Shares Purchased | - | - | - | - | 1,196 | 2,780 | 543 | 13,867 | 1,845 | 7,611 | - | 4,640 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | 190.2% | 241.1% | 88.8% | 78.0% | 53.4% | 67.2% | - | 84.9% |
| S&P 500 Return to Date | - | - | - | - | 104.9% | 93.1% | 74.8% | 31.7% | 37.3% | 31.3% | - | 62.2% |
| Excess Total Return | - | - | - | - | 85.3% | 148.0% | 14.0% | 46.4% | 16.1% | 35.8% | - | 22.7% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | 86% | 91% | 70% | 86% | 81% | 90% | - | 81% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at CORT make a trade.
Creating a free account takes less than one minute